Methylparaben
Standardized Chemical AllergenCell-mediated ImmunityIncreased Histamine ReleaseUS-FDASourced from openFDA
GET
/api/v1/drug/methylparabenIndications
Sourced from openFDA- USES: • For the temporary relief of symptoms including: • headache • liver support • muscle weakness • skin irritation • poor muscle coordination These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R51.9
Dosage & administration
Sourced from openFDADIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAIf pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.
Clinical trials
The 10 most recently updated of 44 ClinicalTrials.gov registrations naming Methylparaben as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat PainRecruiting · Phase 2 · Interventional · 24 enrolled · Wake Forest University Health SciencesNCT07053774updated 2026-05-26
- Pregabalin Phonophoresis and MET for Knee OsteoarthritisRecruiting · Interventional · 35 enrolled · University of FaisalabadNCT07598474updated 2026-05-20
- Oxytocin Substitution Therapy in Patients With Central Diabetes InsipidusRecruiting · Phase 2 · Interventional · 112 enrolled · University Hospital, Basel, SwitzerlandNCT06036004updated 2026-05-06
- Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to RadiotherapyActive not recruiting · Phase 1 · Interventional · 20 enrolled · Instituto Nacional de Cancer, BrazilNCT05308732updated 2026-05-01
- Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During RadioteraphyWithdrawn · Phase 2 · Interventional · 0 enrolled · Instituto Nacional de Cancer, BrazilNCT06708702updated 2026-04-09
- Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux DiseaseRecruiting · Interventional · 208 enrolled · Devintec SaglNCT06984484updated 2026-04-08
- Skin Barrier Function and Inflammation in Aging: The BIA StudyRecruiting · Phase 4 · Interventional · 32 enrolled · University of California, San FranciscoNCT06750653updated 2026-03-06
- Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation DermatitisRecruiting · Interventional · 54 enrolled · University of the PhilippinesNCT05079763updated 2026-01-12
- Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years OldNot yet recruiting · Phase 3 · Interventional · 20 enrolled · Immedica Pharma ABNCT05249556updated 2025-11-28
- Effect of Omega 3 on Oxidative Stress and Nutritional Status of Children on Regular DialysisRecruiting · Interventional · 45 enrolled · Tanta UniversityNCT06268184updated 2024-07-18
Frequently asked questions
- What is Methylparaben used for?
- According to FDA labeling, Methylparaben carries indications including: USES: • For the temporary relief of symptoms including: • headache • liver support • muscle weakness • skin irritation • poor muscle coordination These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Methylparaben?
- Methylparaben is classified as Standardized Chemical Allergen, Cell-mediated Immunity, Increased Histamine Release.
Note. Data for
methylparaben is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.